{
    "nct_id": "NCT03292328",
    "official_title": "Yoga for Chemotherapy-Induced Peripheral Neuropathy in Breast and GYN Cancer Survivors: A Pilot Study",
    "inclusion_criteria": "* English-speaking\n* Age >/= 18 years old\n* Survivors with a primary diagnosis of stage I-III breast, ovarian uterine, or endometrial cancer\n* Moderate to severe chemotherapy induced peripheral neuropathy, defined by symptoms such as numbness, tingling, or pain ratings of 4 or greater on a 0-10 numeric rating scale\n* Have completed neurotoxic chemotherapy, i.e. taxanes (paclitaxel, docetaxel) and platinum (carboplatin) at least 3 months prior to enrollment\n* If taking anti-neuropathy medications, they are on a stable regiment (no change in 3 months)\n* ECOG performance status 0-2\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Participants with metastatic disease\n* Participants who are currently receiving physical therapy or practicing yoga for any reason\n\nControl Group - Inclusion/Exclusion Criteria\n\nInclusion Criteria:\n\n* English speaking\n* Age >/= 18 years old\n* Survivors with a primary diagnosis of Stage I-III breast, ovarian, uterine, or endometrial cancer\n* CIPN symptoms such as numbness, tingling, or pain ratings < 2 on a 0-10 NRS scale\n* Have completed neurotoxic chemotherapy, i.e. taxanes (paclitaxel, docetaxel) and platinum (carboplatin) at least 3 months prior to enrollment\n* ECOG performance status 0-2\n\nExclusion Criteria:\n\n* Patients with metastatic disease\n* Patients taking anti-neuropathy medication\n* Patients who are currently receiving physical therapy or practicing yoga for any reason",
    "miscellaneous_criteria": ""
}